Evaluating Long-Term Benefits of Chronic Azithromycin. Furthering Our Quest for Precision Medicine
- PMID: 31810394
- PMCID: PMC7049931
- DOI: 10.1164/rccm.201911-2234ED
Evaluating Long-Term Benefits of Chronic Azithromycin. Furthering Our Quest for Precision Medicine
Comment on
-
Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis.Am J Respir Crit Care Med. 2020 Feb 15;201(4):430-437. doi: 10.1164/rccm.201906-1206OC. Am J Respir Crit Care Med. 2020. PMID: 31661302 Free PMC article.
References
-
- Jaffé A, Francis J, Rosenthal M, Bush A. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet. 1998;351:420. - PubMed
-
- Mogayzel PJ, Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, et al. Pulmonary Clinical Practice Guidelines Committee. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187:680–689. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical